These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32595610)

  • 1. The Diverse Search for Synthetic, Semisynthetic and Natural Product Antibiotics From the 1940s and Up to 1960 Exemplified by a Small Pharmaceutical Player.
    Leisner JJ
    Front Microbiol; 2020; 11():976. PubMed ID: 32595610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
    Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
    Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of Antibiotics Research.
    Mohr KI
    Curr Top Microbiol Immunol; 2016; 398():237-272. PubMed ID: 27738915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit
    Pollo LAE; Martin EF; Machado VR; Cantillon D; Wildner LM; Bazzo ML; Waddell SJ; Biavatti MW; Sandjo LP
    Front Microbiol; 2020; 11():622629. PubMed ID: 33537021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old and modern antibiotic structures with potential for today's infections.
    Newman DJ
    ADMET DMPK; 2022; 10(2):131-146. PubMed ID: 35350115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthetic Antimycobacterial C-3 Silicate and C-3/C-21 Ester Derivatives of Fusidic Acid: Pharmacological Evaluation and Stability Studies in Liver Microsomes, Rat Plasma, and
    Njoroge M; Kaur G; Espinoza-Moraga M; Wasuna A; Dziwornu GA; Seldon R; Taylor D; Okombo J; Warner DF; Chibale K
    ACS Infect Dis; 2019 Sep; 5(9):1634-1644. PubMed ID: 31309823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for natural products in 21
    Wright GD
    Nat Prod Rep; 2017 Jul; 34(7):694-701. PubMed ID: 28569300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic Discovery with Synthetic Fermentation: Library Assembly, Phenotypic Screening, and Mechanism of Action of β-Peptides Targeting Penicillin-Binding Proteins.
    Stepek IA; Cao T; Koetemann A; Shimura S; Wollscheid B; Bode JW
    ACS Chem Biol; 2019 May; 14(5):1030-1040. PubMed ID: 30990649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural product source material use in the pharmaceutical industry: the Glaxo experience.
    Turner DM
    J Ethnopharmacol; 1996 Apr; 51(1-3):39-43; discussion 44. PubMed ID: 9213629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products That Target Virulence Factors in Antibiotic-Resistant
    Wu SC; Liu F; Zhu K; Shen JZ
    J Agric Food Chem; 2019 Dec; 67(48):13195-13211. PubMed ID: 31702908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Screening of Biodiversity for Antibiotic Discovery.
    Terekhov SS; Osterman IA; Smirnov IV
    Acta Naturae; 2018; 10(3):23-29. PubMed ID: 30397523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotics: present and future].
    Bérdy J
    Orv Hetil; 2013 Apr; 154(15):563-73. PubMed ID: 23567874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The search for novel antibiotics--strategies and current approaches].
    Schmid P
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):498-512. PubMed ID: 25872259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-lethal activity of small molecules from natural sources and their synthetic derivatives against biofilm forming nosocomial pathogens.
    Villa F; Villa S; Gelain A; Cappitelli F
    Curr Top Med Chem; 2013; 13(24):3184-204. PubMed ID: 24200356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.